1. Home
  2. LEXX vs SFHG Comparison

LEXX vs SFHG Comparison

Compare LEXX & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$8.21

Market Cap

8.7M

Sector

Health Care

ML Signal

HOLD

Logo Samfine Creation Holdings Group Limited Ordinary Share

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$2.52

Market Cap

9.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEXX
SFHG
Founded
2004
1993
Country
Canada
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
9.9M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
LEXX
SFHG
Price
$8.21
$2.52
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
106.4K
46.4K
Earning Date
04-13-2026
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$705,923.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$601.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
52.05
N/A
52 Week Low
$0.35
$0.32
52 Week High
$8.26
$3.17

Technical Indicators

Market Signals
Indicator
LEXX
SFHG
Relative Strength Index (RSI) N/A 40.90
Support Level N/A $2.26
Resistance Level N/A $2.60
Average True Range (ATR) 0.00 0.11
MACD 0.00 -0.01
Stochastic Oscillator 0.00 39.29

Price Performance

Historical Comparison
LEXX
SFHG

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: